Why Does Aspirin Fail in Secondary Cerebrovascular Prevention? A Multicenter Prospective Case - Control Study
Phase
N/ASpan
130 weeksSponsor
Fadoi Foundation, ItalyAssisi
Recruiting
1-1 of 1